.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Julphar
Covington
Baxter
US Department of Justice
Cipla
Healthtrust
Citi
Moodys
Cerilliant

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090892

« Back to Dashboard

NDA 090892 describes NIACIN, which is a drug marketed by Amneal Pharms, Barr, Lannett, Lupin Ltd, Sun Pharma Global, Everylife, Halsey, Hikma Pharms, Impax Labs, Ivax Sub Teva Pharms, Mk Labs, Purepac Pharm, Sandoz, Tablicaps, Watson Labs, and Wockhardt, and is included in twenty-three NDAs. It is available from twelve suppliers. Additional details are available on the NIACIN profile page.

The generic ingredient in NIACIN is niacin. There are fourteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the niacin profile page.

Summary for 090892

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 090892

Ingredient-typeNicotinic Acids

Medical Subject Heading (MeSH) Categories for 090892

Suppliers and Packaging for NDA: 090892

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 090892 ANDA LUPIN LIMITED 57297-222 57297-222-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (57297-222-01)
NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 090892 ANDA LUPIN LIMITED 57297-222 57297-222-02 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (57297-222-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength750MG
Approval Date:Mar 20, 2014TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Queensland Health
Fish and Richardson
McKinsey
Citi
Covington
US Department of Justice
Teva
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot